UK tribunal's hydrocortisone case findings weren’t flawed, appeal court says
( July 28, 2026, 10:40 GMT | Official Statement) -- MLex Summary: The UK's competition court didn’t err when it upheld key findings from the antitrust watchdog over competition breaches in relation to the supply of hydrocortisone tablets, UK appeal judges have ruled. The Court of Appeal ruling came after drugmakers sanctioned over their pricing behaviors, including Auden Mckenzie, challenged a set of rulings by the Competition Appeal Tribunal from 2023 and 2024.Ruling attached....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.